WeVote
Log In

Bill

Bill

SB 1102

pharmacy benefits; prescribing; exemption

57th Legislature - First Regular Session Introduced by Walt Blackman and 6 co-sponsors

Arizona law creates exemption from pharmacy benefits manager regulations for certain prescribing practices, potentially affecting medication access and insurance cost controls.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · SB 1102

Legislative bill overview

SB 1102 creates an exemption from pharmacy benefits manager (PBM) regulations for certain prescribing practices in Arizona. The bill has been signed into law as of March 25, 2025, indicating it addresses perceived issues with how PBMs control medication access and costs through their formulary and prior authorization requirements.

Why is this important

PBMs function as intermediaries between insurers, pharmacies, and patients, controlling which drugs are covered and at what cost. This exemption could affect medication accessibility and affordability for Arizona residents by potentially allowing certain prescribers or prescribing practices to bypass PBM restrictions, though the specific scope depends on exemption details not fully described in the bill summary provided.

Potential points of contention

  • Patient cost implications: Exemptions from PBM oversight could either reduce patient out-of-pocket costs if restrictions are lifted, or increase them if insurers respond by raising premiums or cost-sharing to offset coverage changes
  • Drug selection and clinical appropriateness: Bypassing PBM clinical review processes may improve access to preferred medications but could reduce oversight preventing potentially inappropriate or costlier drug selections
  • Healthcare market effects: Exemptions could incentivize certain prescribing patterns and may disadvantage competing pharmaceutical products, affecting market competition and drug pricing dynamics

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.